Daily consumption of the probiotic strain Lactobacillus salivarius UCC118 helped relieve severity of gastrointestinal (GI) symptoms associated with small intestinal bacterial overgrowth (SIBO), according to a pilot quality improvement study. The study participants (n=29) were recruited from patients who presented to the Cleveland Clinic Center for Gut Rehabilitation and Transplantation outpatient clinic (Cleveland, OH). Participants consumed the probiotic strain Lactobacillus salivarius UCC118 in an oral supplement (108 CFU/capsule daily) for 90 days in addition to standard therapy. GI symptoms consistent…
Daily consumption of the probiotic strain Lactobacillus salivarius UCC118 helped relieve severity of gastrointestinal (GI) symptoms associated with small intestinal bacterial overgrowth (SIBO), according to a pilot quality improvement study. The study participants…
A review published in Alimentary Pharmacology and Therapeutics showed alcohol consumption adversely altered gut microbiota and could lead to negative impacts on the liver. It is well known that alcohol intake directly and adversely affects the liver, but more recently, it has also been clinically shown to impact the gastrointestinal microbiota. To better elucidate this relationship the authors utilized the PubMed data base, to identify and review data from research articles addressing this topic. The studies that the authors identified showed alcohol…
A review published in Alimentary Pharmacology and Therapeutics showed alcohol consumption adversely altered gut microbiota and could lead to negative impacts on the liver. It is well known that alcohol intake directly and adversely affects…
Introduction Certain probiotics have demonstrated significant benefit for maintaining the health of the microbial community in the gut. Lactobacilli have demonstrated the ability to protect the host from pathogenic bacterial strains like Listeria, Salmonella and E .coli.1 Lactobacilli influence immunological and physiological processes in the body. In a large review of various Lactobacillus species, researchers found Lactobacilli efficacious for the treatment of some cancers, vaginal disorders, hypercholesterolemia, H. pylori, oxaluria, mastitis, atopic dermatitis, allergic rhinitis, constipation and ulcerative colitis, diarrhea, and type 2 diabetes.2 While Lactobacilli…
Introduction Certain probiotics have demonstrated significant benefit for maintaining the health of the microbial community in the gut. Lactobacilli have demonstrated the ability to protect the host from pathogenic bacterial strains like Listeria,…
by Bianca Garilli, ND Anxiety comes in a myriad of forms from social anxiety to post traumatic stress disorder with an average onset at 11 years of age. Anxiety is estimated to affect 18% of the US population or 42 million Americans with 4% of the population suffering with severe anxiety.1,2 The more common and easily identifiable symptoms of anxiety include a feeling of dread, edginess or irritation, fear, worry, difficulty with concentration and focus; somatic symptoms may include increased…
by Bianca Garilli, ND Anxiety comes in a myriad of forms from social anxiety to post traumatic stress disorder with an average onset at 11 years of age. Anxiety is estimated to affect…
In this video presentation, Dale Bredesen, MD presents on advances in Alzheimer’s disease research. He proposes that we are entering the era of treatable Alzheimer’s disease. He also discusses mild cognitive impairment (MCI) and subjective cognitive impairment (SCI), conditions that can be precursors to Alzheimer’s disease. Indeed, the opportunity exists to improve our cognition regardless of if these conditions are present. First, Dr. Bredesen discusses some “shocking truths” about Alzheimer’s disease that have come from his 25+ years of research:…
In this video presentation, Dale Bredesen, MD presents on advances in Alzheimer’s disease research. He proposes that we are entering the era of treatable Alzheimer’s disease. He also discusses mild cognitive impairment (MCI)…
by Ashley Jordan Ferira, PhD, RDN Most people have heard of, or know somebody who suffers from irritable bowel syndrome (IBS). IBS is not a single condition but rather a group of symptoms associated with the gastrointestinal (GI) tract that includes abdominal pain and changes in bowel movements such as constipation or diarrhea.1 IBS affects 10-15% of US adults, with women being twice as likely as men to develop IBS.1 Costs associated with treating IBS symptoms are estimated to be $1.7 billion and $10…
by Ashley Jordan Ferira, PhD, RDN Most people have heard of, or know somebody who suffers from irritable bowel syndrome (IBS). IBS is not a single condition but rather a group of symptoms associated…